COMMUNIQUÉS West-GlobeNewswire
-
Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
28/08/2024 - 22:01 -
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
28/08/2024 - 20:48 -
Smart for Life to Attend the Newtopia Now 2024 Conference in Colorado
28/08/2024 - 19:28 -
Justin Baldoni’s doctor available to comment on “It Ends With Us” actor/director receiving groundbreaking regenerative therapy to treat chronic pain
28/08/2024 - 17:33 -
AGAPE ATP Corporation Announces 1-for-20 Reverse Stock Split Effective August 30
28/08/2024 - 15:45 -
Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
28/08/2024 - 15:32 -
IR-MED Appoints Ran Ziskind, Tech Entrepreneur, Growth Manager, and Inventor as Chief Executive Officer
28/08/2024 - 15:15 -
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
28/08/2024 - 15:11 -
Appointment of Chase Hall, M.D., as Chief Medical Advisor
28/08/2024 - 15:01 -
Galecto Announces Reverse Stock Split
28/08/2024 - 15:00 -
Editas Medicine to Participate in Upcoming Investor Conferences
28/08/2024 - 15:00 -
Protect Pharmaceutical Corp. (PRTT) Finalizes the Merger with KARINCA Logistics
28/08/2024 - 15:00 -
Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
28/08/2024 - 15:00 -
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
28/08/2024 - 15:00 -
Lord Jones® Live Resin Vapes and Ice Water Hash Pre-Rolls Now Available Across Canada
28/08/2024 - 15:00 -
HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
28/08/2024 - 14:57 -
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million
28/08/2024 - 14:55 -
Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel
28/08/2024 - 14:40 -
Sienna Senior Living Announces Closing of Common Share Offering for Gross Proceeds of Approximately $144 Million
28/08/2024 - 14:35
Pages